CITYGENINS
A MarginCity Insurance PLC. · Insurance
No lists yet
Create on Stocks pageKey Statistics
City Insurance PLC.
Insurance sector stock listed on DSE since 2007.
Trading Info
Capital Structure
External Links
Valuation
Dividend History
Cash dividend declared, as a percentage of face value, with any bonus shares beside it. A dash means the year was not reported.
EPS History
Share Distribution
The Company has informed that the Board of Directors in its meeting held on October 26, 2026 has resolved the following decision subject to relevant r...
The Company has informed that the Board of Directors in its meeting held on October 26, 2026 has resolved the following decision subject to relevant regulatory authority(ies) approval as applicable: The Board of Directors has decided to purchase a total commercial space of 5,926 (Five Thousand Nine Hundred Twenty-Six) square feet, comprising 5,782 (Five Thousand Seven Hundred Eighty-Two) square feet of office space on the 9th floor and 144 (One Hundred Forty-Four) square feet of car parking space located in the basement, at Gawsia Kashem Center, 10/2, Arambag, Motijheel, Dhaka-1000, at a rate of BDT 11,812.36 (Approx.) per square feet, for a total consideration of BDT 7,00,00,000/- (Taka Seven Crore) only, plus applicable VAT, Tax, Stamp, registration cost and other incidental costs, subject to the approval of the Insurance Development & Regulatory Authority (IDRA) and other relevant regulatory authorities, as applicable.
(Q3 Un-audited): EPS was Tk. 0.95 for July-September 2026 as against Tk. 0.99 for July-September 2025; EPS was Tk. 3.65 for January-September 2026 as...
(Q3 Un-audited): EPS was Tk. 0.95 for July-September 2026 as against Tk. 0.99 for July-September 2025; EPS was Tk. 3.65 for January-September 2026 as against Tk. 2.62 for January-September 2025. NOCFPS was Tk. 4.19 for January-September 2026 as against Tk. 2.39 for January-September 2025. NAV per share was Tk. 27.12 as on September 30, 2026 and Tk. 23.24 as on December 31, 2025. (cont.1) Reasons for deviation: EPS has been decreased for the period from 01st January 2026 to 30th September 2026 (Un-audited) in comparison to the same period of the previous year 2025 because the company's premium income has been decreased. NOCFPS has been increased for the period from 01st January 2026 to 30th September 2026 (Un-audited) in comparison to the same period of the previous year 2025 because the company's management expenses have been decreased. (cont.2) NAV has been increased for the period from 01st January 2026 to 30th September 2026 (Un-audited) in comparison to the same period of the previous year 2025 because the company's investments in Share, Bangladesh Govt. Treasury Bond and FDR have been increased.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.
(Q2 Un-audited): EPS was Tk. 1.60 for April-June 2026 as against Tk. 0.73 for April-June 2025; EPS was Tk. 2.70 for January-June 2026 as against Tk. 1...
(Q2 Un-audited): EPS was Tk. 1.60 for April-June 2026 as against Tk. 0.73 for April-June 2025; EPS was Tk. 2.70 for January-June 2026 as against Tk. 1.63 for January-June 2025. NOCFPS was Tk. 1.97 for January-June 2026 as against Tk. 1.98 for January-June 2025. NAV per share was Tk. 26.30 as on June 30, 2026 and Tk. 22.47 as on June 30, 2025. (cont.1) (Continuation news of CITYGENINS): EPS has been increased for the period from 01st January 2026 to 30th June, 2026 up to 2nd quarter ended on 30 June, 2026 (Un-audited) in comparison to the same period of the previous year because of investment and others income have been increased. NOCFPS has been decreased slightly for the period from 01st January 2026 to 30th June, 2026 up to 2nd quarter ended on 30 June, 2026 (cont.2) (Continuation news of CITYGENINS): (Un-audited) comparison to the same period of the previous year because the company's premium collection decreased. NAVPS has been increased for the period from 01st January 2026 to 30th June, 2026 up to 2nd quarter ended on 30 June, 2026 (Un-audited) in comparison to the same period of the previous year because the company's investment in Bangladesh Govt. Treasury Bond & FDR have been increased.
Credit Rating Information and Services PLC (CRISL) has assigned the rating of the Company as "AAA" along with Stable outlook in consideration of its a...
Credit Rating Information and Services PLC (CRISL) has assigned the rating of the Company as "AAA" along with Stable outlook in consideration of its audited financials up to December 31, 2025 also unaudited financials up to March 31, 2026 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.
(Q1 Un-audited): EPS was Tk. 1.10 for January-March 2026 as against Tk. 0.90 for January-March 2025; NOCFPS was Tk. 1.30 for January-March 2026 as aga...
(Q1 Un-audited): EPS was Tk. 1.10 for January-March 2026 as against Tk. 0.90 for January-March 2025; NOCFPS was Tk. 1.30 for January-March 2026 as against Tk. 1.16 for January-March 2025. NAV per share was Tk. 24.52 as on March 31, 2026 and Tk. 23.24 as on December 31, 2025. Reasons for deviation: EPS has been increased for the period from 1st January 2026 to 31st March, 2026 in comparison (cont.1) to the same period of the previous year 2025 because of investment and others income have been increased. NOCFPS has been increased for the period from 1st January 2026 to 31st March, 2026 in comparison to the same period of the previous year 2025 because the company's agency commission, management expenses have been decreased sharply. (cont.2) NAV has been increased for the period from 1st January 2026 to 31st March, 2026 because the company's investments in FDR and Bangladesh Govt. Treasury Bonds have been increased.
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2025 to the respective shareholders.
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2025 to the respective shareholders.
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors wil...
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 23, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026.
Trading of the shares of the company will resume on 05.03.2026.
Trading of the shares of the company will resume on 05.03.2026.
Momentum
Price ৳130.700.74 · signal 1.01 · hist -0.27
Price vs averages
Go Deeper on This Stock
RSI, MACD, Bollinger Bands, and 12+ indicators — calculated and ready for every listed stock.
Compare Plans
Order Book
Orders waiting to buy and sell on DSE right now. Best bid and ask are free; the full ladder is Pro.
The order book could not be loaded.
Best bid
Spread
Best ask
See the Whole Order Book
Ten price levels on each side, live through the session: how much is queued to buy and to sell, and where.
Compare Plans
Big negotiated deals made outside the normal market. Heavy block activity often signals institutional interest.
Block Trades
See What Big Investors Traded Today
Block transactions reveal institutional buying and selling that don't show up in regular price data.
Compare Plans